REFERENCES
- Lima, G. R., I. R. P. Sales, M. R. D. C. Filho, N. Z. T. Jesus, H. S. Falcão, J. M. Barbosa-Filho, A. G. S. Cabral, et al. 2012. Bioactivities of the genus Combretum (Combretaceae): A review. Mol. 17:9142–9206.
- Mangoyi, R., W. Mafukidze, K. Marobela, and S. Mukanganyama. 2012. Antifungal activities and preliminary phytochemical investigation of Combretum species from Zimbabwe. J. Microb. Biochem. Tech. 4:037–044.
- Navarro-Martinez, D. M., G. F. Cánovas, and J. N. R. Guez-López. 2006. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. JAC. 57:1083–1092.
- Nes, C. R., K. Ujjal, S. J. Liu, K. Ganapathy, F. Villalta, M. R. Waterman, G. I. Lepesheva, et al. 2012. Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms. Biochem J. 443:267–277.
- Rajput, S. B., and S. M. Karuppayil. 2013. Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans. SpringerPlus. 2:26.
- Rates, S. M. K. 2001. Plants as source of drugs. Toxicon. 39:603–613.
- Sanglard, D., F. Ischer, T. Parkinson, D. Falconer, and J. Bille. 2003. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47:2404–2412.
- Subha T. S., and A. Gnanamani. 2008. Effect of active fraction of methanolic extract of Acorus calamus on sterol metabolism of Candida albicans. J. Appl. Biosci. 8:243–250.